These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11504529)

  • 21. [Role of intestinal resection in primary cytoreduction of ovarian cancer].
    Balbi GC; Compagna R; Musone R; Cirelli G; Delli Ponti D; Cassese E; Passaro M; Balbi F; Zarcone R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):100-1. PubMed ID: 11526699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of surgery in ovarian carcinoma.
    Fader AN; Rose PG
    J Clin Oncol; 2007 Jul; 25(20):2873-83. PubMed ID: 17617518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splenectomy in cytoreductive surgery for advanced ovarian cancer.
    Bilgin T; Ozerkan K; Ozan H
    Arch Gynecol Obstet; 2005 Apr; 271(4):329-31. PubMed ID: 14997326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The feasibility and morbidity of distal pancreatectomy in extensive cytoreductive surgery for advanced epithelial ovarian cancer.
    Yildirim Y; Sanci M
    Arch Gynecol Obstet; 2005 Jun; 272(1):31-4. PubMed ID: 15480722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of CA-125 in the management of patients with recurrent epithelial ovarian carcinoma selected for secondary cytoreduction.
    Mahner S; Woelber L; Jung S; Eulenburg CZ; Ihnen M; Schwarz J; Sehouli J; Jaenicke F
    Anticancer Res; 2009 Jul; 29(7):2817-21. PubMed ID: 19596967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
    Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
    J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?
    Zang RY; Li ZT; Tang J; Cheng X; Cai SM; Zhang ZY; Teng NN
    Cancer; 2004 Mar; 100(6):1152-61. PubMed ID: 15022281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.
    Engelen MJ; Kos HE; Willemse PH; Aalders JG; de Vries EG; Schaapveld M; Otter R; van der Zee AG
    Cancer; 2006 Feb; 106(3):589-98. PubMed ID: 16369985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer.
    Alphs HH; Zahurak ML; Bristow RE; Díaz-Montes TP
    Gynecol Oncol; 2006 Dec; 103(3):1048-53. PubMed ID: 16876237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary cytoreductive surgery for isolated nodal recurrence of ovarian cancer.
    Bristow RE
    Ann Surg Oncol; 2004 Jul; 11(7):639-40. PubMed ID: 15197010
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience.
    Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB; Ivanovic AM; Kecmanovic DM
    Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma.
    Reichman TW; Cracchiolo B; Sama J; Bryan M; Harrison J; Pliner L; Harrison LE
    J Surg Oncol; 2005 May; 90(2):51-6; discussion 56-8. PubMed ID: 15844187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical treatment of epithelial ovarian cancer.
    González-Martín AJ
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1125-43. PubMed ID: 15606338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent ovarian carcinoma of low malignant potential: the role of secondary surgical cytoreduction and the prognosis in Chinese patients.
    Zang RY; Yang WT; Shi DR; Xing Y; Cai SM
    J Surg Oncol; 2005 Jul; 91(1):67-72. PubMed ID: 15999350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Splenectomy as part of cytoreductive surgery in ovarian cancer.
    Magtibay PM; Adams PB; Silverman MB; Cha SS; Podratz KC
    Gynecol Oncol; 2006 Aug; 102(2):369-74. PubMed ID: 16631919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How to increase the optimal rate of secondary cytoreductive surgery in recurrent epithelial ovarian cancer].
    Li YF; Li MD; Liu FY; Liu JH; Li JD
    Ai Zheng; 2003 Nov; 22(11):1193-6. PubMed ID: 14613651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytoreductive surgery in patients with stage IV ovarian carcinoma].
    Balbi GC; Compagna R; Musone R; Cirelli G; Sgambato R; Cassese E; Delli Ponti D; Passaro M; Zarcone R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):105-9. PubMed ID: 11526701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant intraarterial chemotherapy and embolization in treatment of advanced ovarian epithelial carcinoma.
    Liu EL; Mi RR
    Chin Med J (Engl); 2004 Oct; 117(10):1547-51. PubMed ID: 15498381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.
    Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A
    Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.